Scholarlink

<p>Smoking and passive smoking significantly increase both the incidence of diabetes and the risk of late complications. While complete smoking and nicotine cessation may lead to weight gain and an increased risk of diabetes, it nevertheless reduces cardiovascular and all-cause mortality. The basic diagnostic assessment (Fagerström test, exhaled carbon monoxide) is essential for successful smoking cessation. Evidence-based pharmacological options include varenicline, nicotine replacement therapy, bupropion and cytisine; glucagon-like peptide&#xa0;1 (GLP-1) receptor agonists may be used as adjunctive treatment for weight control following smoking cessation. Neither heated tobacco products, e‑cigarettes nor smokeless nicotine products (nicotine pouches) are harmless alternatives, they are also associated with an increased risk of diabetes, morbidity, and mortality. Socioeconomic and psychological factors play a&#xa0;significant role in addictive behavior, including smoking, nicotine use and alcohol consumption. Moderate alcohol consumption appears to reduce the risk of diabetes and cardiovascular disease but selection bias and underreporting likely overestimate this effect. Dose-dependent risks, particularly through cancer, liver disease and infections predominate. Infections occur more frequently in individuals with diabetes, often with greater severity and atypical presentation. Unexplained hyperglycemia should always prompt consideration of an infection. Vaccinations are of even greater health relevance for patients with diabetes than for those without.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Rauchen und Nikotinkonsum, erhitzte Tabakprodukte, psychische und sozioökonomische Aspekte von Dependenz, Alkohol, Infektionen, Impfen und Diabetes mellitus (Update 2026)

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月30日

查看全文
  • Helmut Brath,
  • Simone Huber,
  • Verena Parzer,
  • Martin Riesenhuber,
  • Christian Tatschl,
  • Peter Fasching,
  • Martin Clodi

摘要

Smoking and passive smoking significantly increase both the incidence of diabetes and the risk of late complications. While complete smoking and nicotine cessation may lead to weight gain and an increased risk of diabetes, it nevertheless reduces cardiovascular and all-cause mortality. The basic diagnostic assessment (Fagerström test, exhaled carbon monoxide) is essential for successful smoking cessation. Evidence-based pharmacological options include varenicline, nicotine replacement therapy, bupropion and cytisine; glucagon-like peptide 1 (GLP-1) receptor agonists may be used as adjunctive treatment for weight control following smoking cessation. Neither heated tobacco products, e‑cigarettes nor smokeless nicotine products (nicotine pouches) are harmless alternatives, they are also associated with an increased risk of diabetes, morbidity, and mortality. Socioeconomic and psychological factors play a significant role in addictive behavior, including smoking, nicotine use and alcohol consumption. Moderate alcohol consumption appears to reduce the risk of diabetes and cardiovascular disease but selection bias and underreporting likely overestimate this effect. Dose-dependent risks, particularly through cancer, liver disease and infections predominate. Infections occur more frequently in individuals with diabetes, often with greater severity and atypical presentation. Unexplained hyperglycemia should always prompt consideration of an infection. Vaccinations are of even greater health relevance for patients with diabetes than for those without.